in this issue
People & Business :: M&A
Bayer to Acquire Teva’s U.S. Animal Health Business for $145 Million
1:43 PM MDT | September 14, 2012 | Deepti Ramesh
Bayer and Teva Pharmaceutical Industries (Petach Tikva, Israel) say that Bayer HealthCare has signed an agreement to acquire Teva's U.S. animal health business for up to $145 million. The purchase price includes an upfront payment of $60 million and a total of $85 million in milestone payments, which are linked to the successful and timely achievement of manufacturing and sales targets. The acquisition will reinforce the food animal franchise of Bayer HealthCare by providing a range of anti-infective solutions for livestock and by introducing reproductive...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee